The Center for Antibody Technologies is a cutting-edge biotechnology brand that is dedicated to addressing critical health challenges in tropical regions. Our mission is to harness the power of science for the benefit of society. Specializing in antibody discovery and synthetic biology, we focus on developing affordable biotherapeutics and diagnostics for neglected tropical diseases and infectious diseases.

Using innovative phage display technology, DNA sequencing, and synthetic biology, we unlock the potential of human monoclonal antibodies and nanobodies. Our expertise lies in creating specialized monoclonal antibodies with unique binding properties, allowing for broad neutralization or targeted therapy. We are particularly invested in neutralizing protein-based toxins from snakes, scorpions, spiders, and bees, aiming to replace current therapies with recombinant antivenoms.

At the Center for Antibody Technologies, we are driven by the belief that science can make a difference in society. Join us in this important mission and be a part of groundbreaking research and innovation. Located at DTU Bioengineering in Denmark, we are at the forefront of antibody technology.

Visit our website to learn more about our work and connect with us today